@article{d7a1d40e3ab24def8ede34d20565f1bc,
title = "Impact of COVID-19 on mental health research: is this the breaking point?",
abstract = "There are many structural problems facing the UK at present, from a weakened National Health Service to deeply ingrained inequality. These challenges extend through society to clinical practice and have an impact on current mental health research, which was in a perilous state even before the coronavirus pandemic hit. In this editorial, a group of psychiatric researchers who currently sit on the Academic Faculty of the Royal College of Psychiatrists and represent the breadth of research in mental health from across the UK discuss the challenges faced in academic mental health research. They reflect on the need for additional investment in the specialty and ask whether this is a turning point for the future of mental health research.",
author = "Oli Sparasci and Kamaldeep Bhui and Asit Biswas and Samuel Chamberlain and Bernadka Dubicka and Robert Dudas and Saeed Farooq and Tamsin Ford and Nusrat Husain and Ian Jones and Helen Killaspy and William Lee and Anne Lingford-Hughes and Ciaran Mulholland and Judy Rubinsztein and Rohit Shankar and Aditya Sharma and Lindsey Sinclair and James Stone and Allan Young",
note = "Funding Information: K.B. is the Editor-in-Chief of the British Journal of Psychiatry. S.C. is funded by the Wellcome Trust, he has received honoraria from Elsevier and previously consulted for promentis. B.D. receives funding from the NIHR HTA programme. T.F. receives funding from UKRI to track the impact of COVID-19 on the mental health of children and young people and consults for Place2Be. N.H. is the chair of board of trustees of Manchester Global Foundation a Charitable Incorporated Organisation registered in England and Wales. He has received honorarium and travel grants from various pharmaceutical industries. He is an NIHR senior investigator. I.J. receives funding from Health and Care Research Wales to study the impact of COVID-19 on people with lived experience of mental illness. A.L.-H. is a Handling Editor of BJPsych and was the immediate past chair of the Academic Faculty of the Royal College of Psychiatrists; she has received research support and honoraria from Lundbeck, GSK and Alcarelle, paid consultancy to Silence and unpaid consultancy to AstraZeneca, Opiant, Britannia Pharmaceuticals outside the submitted work. R.S. has received support and honoraria from LivaNova, UCB, Eisai, Veriton Pharma, Bial, Averelle and GW pharmaceuticals outside the submitted work. L.S. Is funded by a Junior Fellowship from the Alzheimer's Society. J.S. has been principal investigator or chief investigator on studies sponsored by Takeda, Janssen and Lundbeck Plc. He has attended an Investigators{\textquoteright} meeting run by Allergan Plc. A.Y. is deputy Editor of BJPsych Open, has received payment for lectures or advisory work from: Astrazeneca, Eli Lilly, Lundbeck, Sunovion, Servier, LivaNova, Janssen, Allegan, Bionomics, Sumitomo Dainippon Pharma, COMPASS. Is a consultant to Johnson & Johnson and LivaNova. Received honoraria for attending advisory boards and presenting talks at meetings organised by LivaNova. Principal investigator in the Restore-Life VNS registry study funded by LivaNova. Principal investigator on ESKETINTRD3004. Is the principal investigator on {\textquoteleft}The Effects of Psilocybin on Cognitive Function in Healthy Participants.{\textquoteright} Is principal investigator on {\textquoteleft}The Safety and Efficacy of Psilocybin in Participants with Treatment-Resistant Depression (P-TRD).{\textquoteright} UK chief investigator for Novartis MDD study MIJ821A12201. Grant funding (past and present): NIMH (USA); CIHR (Canada); NARSAD (USA); Stanley Medical Research Institute (USA); MRC (UK); Wellcome Trust (UK); Royal College of Physicians (Edin); BMA (UK); UBC-VGH Foundation (Canada); WEDC (Canada); CCS Depression Research Fund (Canada); MSFHR (Canada); NIHR (UK). Janssen (UK). No shareholdings in pharmaceutical companies. W.L. is deputy editor of the British Journal of Psychiatry. A.B., R.D., S.F., H.K., C.M., J.R., A.S. and O.S. have no competing interests to declare. Publisher Copyright: Copyright {\textcopyright} The Author(s), 2022. Published by Cambridge University Press on behalf of the Royal College of Psychiatrists.",
year = "2022",
month = may,
day = "12",
doi = "10.1192/bjp.2022.8",
language = "English",
volume = "220",
pages = "254--256",
journal = "The British journal of psychiatry : the journal of mental science",
issn = "0007-1250",
publisher = "Cambridge University Press",
number = "5",
}
